Research Article
High Prevalence of Cardiovascular Disease in End-Stage Kidney Disease Patients Ongoing Hemodialysis in Peru: Why Should We Care About It?
Table 1
Clinical and biochemical data in the population at CNSR categorized by cardiovascular disease.
| | | With CVD
(82%) | Without CVD
(18%) | value |
| | Age (years) | 56.7 ± 13.6 | 40.4 ± 11.4 | <0.001 | | Waist circumference (cm) | 94.3 ± 13.5 | 90.0 ± 13.2 | 0.162 | | Effective blood flow (mL/min) | 321.6 ± 33.1 | 341.1 ± 36.3 | 0.006 | | Total cholesterol (mg/dL) | 163.5 (49.7) | 169.0 (26.5) | 0.814 | | LDL-C (mg/dL) | 98.0 (33.7) | 101.0 (23.5) | 0.927 | | HDL-C (mg/dL) | 40.0 (9.7) | 42.0 (7.5) | 0.277 | | Triglycerides (mg/dL) | 150.0 (130.5) | 136.0 (113.0) | 0.652 | | Calcium (mg/dL) | 9.5 (2.5) | 9.3 (1.6) | 0.217 | | Hemoglobin (mg/dL) | 12.0 (1.4) | 11.4 (5.1) | 0.084 | | CRP (mg/dL) | 0.5 (0.8) | 0.4 (0.4) | 0.015 | | PTH (pg/mL) | 356.9 (427.3) | 475.2 (50.0) | 0.235 |
|
|
CNSR: Centro Nacional De Salud Renal; CRP: C-reactive protein; PTH: parathyroid hormone.
Mean ± SD Median (interquartile range).
|
